These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 12384558

  • 1. Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation.
    Neef R, Kuske MA, Pröls E, Johnson JP.
    Cancer Res; 2002 Oct 15; 62(20):5920-9. PubMed ID: 12384558
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Patterns of melastatin mRNA expression in melanocytic tumors.
    Deeds J, Cronin F, Duncan LM.
    Hum Pathol; 2000 Nov 15; 31(11):1346-56. PubMed ID: 11112208
    [Abstract] [Full Text] [Related]

  • 4. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.
    Fagiani E, Giardina G, Luzi L, Cesaroni M, Quarto M, Capra M, Germano G, Bono M, Capillo M, Pelicci P, Lanfrancone L.
    Cancer Res; 2007 Apr 01; 67(7):3064-73. PubMed ID: 17409413
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T, Stolz W, Welsh J, Jung B, Kerbel RS, Kobayashi H, Landthaler M, McClelland M.
    Clin Cancer Res; 1998 Mar 01; 4(3):791-7. PubMed ID: 9533549
    [Abstract] [Full Text] [Related]

  • 6. Ferritin contributes to melanoma progression by modulating cell growth and sensitivity to oxidative stress.
    Baldi A, Lombardi D, Russo P, Palescandolo E, De Luca A, Santini D, Baldi F, Rossiello L, Dell'Anna ML, Mastrofrancesco A, Maresca V, Flori E, Natali PG, Picardo M, Paggi MG.
    Clin Cancer Res; 2005 May 01; 11(9):3175-83. PubMed ID: 15867210
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.
    Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347
    [Abstract] [Full Text] [Related]

  • 9. Analysis of APAF-1 expression in human cutaneous melanoma progression.
    Baldi A, Santini D, Russo P, Catricalà C, Amantea A, Picardo M, Tatangelo F, Botti G, Dragonetti E, Murace R, Tonini G, Natali PG, Baldi F, Paggi MG.
    Exp Dermatol; 2004 Feb 07; 13(2):93-7. PubMed ID: 15009102
    [Abstract] [Full Text] [Related]

  • 10. Clone 10d/BM28 (CDCL1), an early S-phase protein, is an important growth regulator of melanoma.
    Spanjaard RA, Lee PJ, Sarkar S, Goedegebuure PS, Eberlein TJ.
    Cancer Res; 1997 Nov 15; 57(22):5122-8. PubMed ID: 9371513
    [Abstract] [Full Text] [Related]

  • 11. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
    Petersson S, Shubbar E, Enerbäck L, Enerbäck C.
    Melanoma Res; 2009 Aug 15; 19(4):215-25. PubMed ID: 19521263
    [Abstract] [Full Text] [Related]

  • 12. Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation.
    Meije CB, Hakvoort TB, Swart GW, Westerhof W, Lamers WH, Das PK.
    J Pathol; 2002 Jan 15; 196(1):51-8. PubMed ID: 11748642
    [Abstract] [Full Text] [Related]

  • 13. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma.
    Massi D, Naldini A, Ardinghi C, Carraro F, Franchi A, Paglierani M, Tarantini F, Ketabchi S, Cirino G, Hollenberg MD, Geppetti P, Santucci M.
    Hum Pathol; 2005 Jun 15; 36(6):676-85. PubMed ID: 16021575
    [Abstract] [Full Text] [Related]

  • 14. Loss of EphB6 expression in metastatic melanoma.
    Hafner C, Bataille F, Meyer S, Becker B, Roesch A, Landthaler M, Vogt T.
    Int J Oncol; 2003 Dec 15; 23(6):1553-9. PubMed ID: 14612926
    [Abstract] [Full Text] [Related]

  • 15. Induction of apoptosis by Hax-1 siRNA in melanoma cells.
    Li WB, Feng J, Geng SM, Zhang PY, Yan XN, Hu G, Zhang CQ, Shi BJ.
    Cell Biol Int; 2009 Apr 15; 33(4):548-54. PubMed ID: 19254774
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents.
    Zanon M, Piris A, Bersani I, Vegetti C, Molla A, Scarito A, Anichini A.
    Cancer Res; 2004 Oct 15; 64(20):7386-94. PubMed ID: 15492260
    [Abstract] [Full Text] [Related]

  • 18. cDNA-array profiling of melanomas and paired melanocyte cultures.
    Mischiati C, Natali PG, Sereni A, Sibilio L, Giorda E, Cappellacci S, Nicotra MR, Mariani G, Di Filippo F, Catricalà C, Gambari R, Grammatico P, Giacomini P.
    J Cell Physiol; 2006 Jun 15; 207(3):697-705. PubMed ID: 16523488
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.